ETC
NVAX icon

Exchange Traded Concepts’s Novavax NVAX Stock Holding History

Exchange Traded Concepts’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-915
Closed -$47K – 1262
2022
Q2 		$47K Buy
+915
New +$47.4K ﹤0.01% 918
2022
Q1 		– Sell
-523
Closed -$75K – 1311
2021
Q4 		$75K Buy
+523
New +$89.9K ﹤0.01% 892
2021
Q2 		– Sell
-774
Closed -$140K – 1182
2021
Q1 		$140K Sell
774
-613
-44% -$122K 0.01% 696
2020
Q4 		$155K Buy
+1,387
New +$147K 0.01% 643

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Exchange Traded Concepts's NVAX Position: Q3 2022 in Review

Exchange Traded Concepts sold out of Novavax (NVAX) in Q3 2022, closing a stake of 915 shares — an estimated $47K sold.

Exchange Traded Concepts first reported a position in NVAX in Q4 2020 and held it in 4 quarters. The position peaked at $155K in Q4 2020. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Exchange Traded Concepts reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Exchange Traded Concepts sold 915 Novavax shares in Q3 2022, an estimated $47K.
  • Exchange Traded Concepts first reported a position in Novavax in Q4 2020 and held it in 4 quarters.
  • Exchange Traded Concepts's Novavax position peaked at $155K in Q4 2020.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Exchange Traded Concepts's 13F filing for Q3 2022, filed 7 Oct 2022.